Pharmaceutical - xyrem (sodium oxybate)
Ended Awarded Last action
- Contract number
- 36C26026F0059
- Awardee
-
Amneal Pharmaceuticals Of New York, LLC UEI LVEBAQTPN615
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $319,399
Award facts
- Contract value 100% obligated
- $319,399.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Brookhaven, NY, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $7,927 | |
| Other Administrative Action | $0 | |
| Original award | $311,472 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a delivery order contract to Amneal Pharmaceuticals of New York, LLC on November 1, 2025, for the supply of Xyrem (sodium oxybate) pharmaceutical products. This firm fixed-price delivery order carries a ceiling value of $319.4K and extends through October 31, 2026, with performance taking place in Brookhaven, New York. The contract incorporates 2026 pricing increases and reflects updated dosage requirements. This delivery order was issued under the GSA Multiple Award Schedule for Pharmaceuticals and Drugs (FSS-61-IB) with no set-aside designation, indicating open competition on the federal marketplace.
Amneal Pharmaceuticals has established itself as a specialized supplier of sodium oxybate products to the Veterans Affairs system, having completed three prior delivery orders under this same schedule between November 2023 and November 2025, collectively valued at approximately $670K. The company currently maintains four prime federal indefinite delivery vehicles, including a $2.5M Blanket Purchase Agreement with the National Acquisition Center for sodium oxybate supply and a $1.71M Federal Supply Schedule contract with Veterans Integrated Service Network 12. Xyrem is a critical pharmaceutical used primarily to treat narcolepsy, addressing significant veteran healthcare needs within the VA system.
Quick answers
Who was awarded contract 36C26026F0059?
36C26026F0059 was awarded to Amneal Pharmaceuticals Of New York, LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on November 1, 2025.
How much is contract 36C26026F0059 worth?
The government has obligated $319,399 on 36C26026F0059.
Is contract 36C26026F0059 an order under another contract?
Yes. 36C26026F0059 is a delivery order under 36F79722D0161, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26026F0059 competed?
The extent of competition for 36C26026F0059 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award